Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. (Q35551832)
Jump to navigation
Jump to search
scientific article published on August 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. |
scientific article published on August 2002 |
Statements
1 reference
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13. (English)
1 reference
Valesini G
1 reference
Pittoni V
1 reference
Bombardieri M
1 reference
Spinelli FR
1 reference
Scrivo R
1 reference
Alessandri C
1 reference
Conti F
1 reference
Spadaro A
1 reference
1 August 2002
1 reference
1 reference
Identifiers
1 reference